IFTIKHAR HUSSAIN: Open Payments
NPI 1205854015 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,719 in 171 payments from 18 companies in 2025. Trend: 2023 $6,072 · 2024 $37,709 · 2025 $12,719
Food & beverage: $5,099Speaker / faculty: $3,600Consulting: $2,292Travel & lodging: $1,694Education: $34
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $3,755 |
| GENZYME CORPORATION | 28 | $3,239 |
| Novartis Pharmaceuticals Corporation | 16 | $1,412 |
| AstraZeneca Pharmaceuticals LP | 32 | $1,288 |
| Insmed, Inc. | 12 | $1,269 |
| CSL Behring | 13 | $241 |
| PFIZER INC. | 12 | $241 |
| GlaxoSmithKline, LLC. | 14 | $203 |
| Grifols USA, LLC | 8 | $188 |
| Blueprint Medicines Corporation | 4 | $185 |
Products named: EBGLYSS, DUPIXENT, AIRSUPRA, FASENRA, AYVAKIT, BREZTRI, CIBINQO, TEZSPIRE.
Industry payments across OK — which companies pay providers there.
